Keywords: DKD; diabetic kidney disease; RAAS; renin-angiotensin-aldosterone system; ESRD; end-stage renal disease; T1DM; type I diabetes mellitus; T2DM; type II diabetes mellitus; CVD; cardiovascular disease; GFR; glomerular filtration rate; AER; albumin excretion
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: GCGR; glucagon receptor; cAMP; cyclic-adenosine monophosphate; T2DM; type 2 diabetes mellitus; SGLT-2; sodium-glucose cotransporter-2; HGP; hepatic glucose production; GPCRs; G-protein coupled receptors; SAR; structure-activity relationship; Ser; Serine;
Keywords: T2DM; type 2 diabetes; IR; insulin resistance; HbA1c; glycated hemoglobin A1c; GLUT-4; glucose transporter4; GLP-1; glucagon-like peptide-1; DPP4; dipeptidyl peptidase; eGFR; estimated glomerular filtration rate; HF; heart failure; UKPDS; United Kingdom P
Keywords: ACE-I; Angiotensin Converting Enzyme Inhibitors; ARNI; Angiotensin Receptor Neprilysin Inhibitor; CMS; Centers for Medicare and Medicaid Services; CRT; cardiac resynchronization therapy; GDMT; guideline directed medical therapy; HCS; health care system; H
Keywords: AMPK; AMP-activated protein kinase; CHD; Coronary Heart Disease; CI; Confidence Interval; CV; Cardiovascular; DPP-IV inhibitors; Dipeptidyl peptidase-4 inhibitors; GLP-1 receptor agonists; Glucagon-like peptide-1 receptor agonists; HF; Heart Failure; HR;
Keywords: monogenic diabetes; young type 2 diabetes; personalised medicine; CRP; C-reactive protein; HNF1A; hepatocyte nuclear factor 1 alpha; HNF4A; hepatocyte nuclear factor 4 alpha; HNF1B; hepatocyte nuclear factor 1 beta; GCK; glucokinase; IPSAD; International
Keywords: DPP-4; SGLT-2; GLP-1 Agonists; cardiovascular; type 2 diabetes;
Keywords: Familial glycosuria; SGLT-2; Kidney; Glucose
Keywords: Type 2 diabetes; Cardiovascular; Glucose; GLP-1; DPP-4; SGLT-2
Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the 18F-FDG PET/CT mediastinal nodal staging of non-small cell lung cancer
Keywords: GLUT-1; SGLT-1; SGLT-2; Mediastinal lymph node; False negative; True positive; 18F-FDG PET/CT; Non-small cell lung cancer;
Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions
Keywords: APJ; apelin receptor; CCK; cholecystokinin; DIO; diet induced obese; DPP; 4 dipeptidylpeptidase-4; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; KRB; krebs ringer bicarbonate; pGlu; pyroglutamyl; SGLT-2; sodium glucose
Protective effects of (-)-epicatechin and the colonic metabolite 3,4-dihydroxyphenylacetic acid against glucotoxicity-induced insulin signalling blockade and altered glucose uptake and production in renal tubular NRK-52E cells
Keywords: Colonic-derived flavonoid metabolites; Epicatechin; Glucose homeostasis; Glucotoxicity; Insulin signalling pathway; NRK-52E cells; AKT/PKB; protein kinase B; AMPK; 5â²-AMP-activated protein kinase; DHBA; 2,3-dihydroxybenzoic acid; DHPAA; 3,4-dihydroxyphe
Nrf2 activator for the treatment of kidney diseases
Keywords: Kidney diseases; Nuclear factor erythroid 2-related factor 2 (Nrf2); Clinical endpoints; Glomerular filtration rate (GFR); ACEi; angiotensin-converting enzyme inhibitors; AKI; acute kidney injury; ALS; amyotrophic lateral sclerosis; ARB; angiotensin II re
N-Glycoform-dependent interactions of megalin with its ligands
Keywords: DBP; vitamin D-binding protein; Fut8; α1,6-fucosyltransferase; JCGGDB; Japan Consortium for Glycobiology and Glycotechnology Database; Kan; kanamycin; LCA; Lens culinaris agglutinin; LRP; LDL receptor-related protein; MAS; Matsunami Adhesive Silane; NP-4